{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:04:07Z","timestamp":1772456647073,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R278-A16459"],"award-info":[{"award-number":["R278-A16459"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R266-2017-4029"],"award-info":[{"award-number":["R266-2017-4029"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10014-022-00436-3","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T09:13:44Z","timestamp":1654766024000},"page":"200-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Loss of H3K27me3 in WHO grade 3 meningioma"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5930-0636","authenticated-orcid":false,"given":"Andrea Daniela","family":"Maier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Beltoft","family":"Br\u00f8chner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mirian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeppe","family":"Haslund-Vinding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Jiri","family":"Bartek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas J.","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frantz Rom","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Scheie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiit","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"issue":"suppl_4","key":"436_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015. Neuro Oncol. 20(suppl_4):iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro Oncol."},{"key":"436_CR2","unstructured":"Louis D, Ohgaki H, Wiestler O, Cavenee W (2016) WHO Classification of Tumours of the Central Nervous System. 4th editio. International Agency for Research on Cancer. World Health Organization"},{"key":"436_CR3","unstructured":"WHO Classification of Tumours Editorial Board (2021) World Health Organization Classification of Tumours of the Central Nervous System. 5th ed."},{"issue":"8","key":"436_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"436_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-019-01093-5","author":"AD Maier","year":"2019","unstructured":"Maier AD, Bartek J, Eriksson F et al (2019) Clinical and histopathological predictors of outcome in malignant meningioma. Neurosurg Rev. https:\/\/doi.org\/10.1007\/s10143-019-01093-5","journal-title":"Neurosurg Rev"},{"key":"436_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-322257","author":"C Mirian","year":"2020","unstructured":"Mirian C, Duun-Henriksen AK, Juratli T et al (2020) Poor prognosis associated with TERT gene alterations in meningioma is independent of the WHO classification: an individual patient data meta-analysis. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2019-322257","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"436_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","volume":"140","author":"P Sievers","year":"2020","unstructured":"Sievers P, Hielscher T, Schrimpf D et al (2020) CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol 140(3):409\u2013413. https:\/\/doi.org\/10.1007\/s00401-020-02188-w","journal-title":"Acta Neuropathol"},{"issue":"1","key":"436_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M et al (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. a RANO review. J Neurosurg 122(1):4\u201323. https:\/\/doi.org\/10.3171\/2014.7.JNS131644","journal-title":"J Neurosurg"},{"issue":"10","key":"436_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12102792","volume":"12","author":"P Das","year":"2020","unstructured":"Das P, Taube JH (2020) Regulating methylation at h3k27: a trick or treat for cancer cell plasticity. Cancers (Basel) 12(10):1\u201333. https:\/\/doi.org\/10.3390\/cancers12102792","journal-title":"Cancers (Basel)"},{"issue":"2","key":"436_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00401-019-02025-9","volume":"138","author":"K Filipski","year":"2019","unstructured":"Filipski K, Braun Y, Zinke J et al (2019) Lack of H3K27 trimethylation is associated with 1p\/19q codeletion in diffuse gliomas. Acta Neuropathol 138(2):331\u2013334. https:\/\/doi.org\/10.1007\/s00401-019-02025-9","journal-title":"Acta Neuropathol"},{"issue":"1","key":"436_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/modpathol.2015.134","volume":"29","author":"IM Schaefer","year":"2016","unstructured":"Schaefer IM, Fletcher CDM, Hornick JL (2016) Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics. Mod Pathol 29(1):4\u201313. https:\/\/doi.org\/10.1038\/modpathol.2015.134","journal-title":"Mod Pathol"},{"issue":"6216","key":"436_CR12","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1253799","volume":"346","author":"K Funato","year":"2014","unstructured":"Funato K, Major T, Lewis PW, Allis CD, Tabar V (2014) Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science (80\u2013) 346(6216):1529\u20131533. https:\/\/doi.org\/10.1126\/science.1253799","journal-title":"Science (80\u2013)"},{"issue":"35","key":"436_CR13","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1038\/sj.onc.1205651","volume":"21","author":"M Ehrlich","year":"2002","unstructured":"Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21(35):5400\u20135413. https:\/\/doi.org\/10.1038\/sj.onc.1205651","journal-title":"Oncogene"},{"issue":"6","key":"436_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","volume":"130","author":"D Castel","year":"2015","unstructured":"Castel D, Philippe C, Calmon R et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130(6):815\u2013827. https:\/\/doi.org\/10.1007\/s00401-015-1478-0","journal-title":"Acta Neuropathol"},{"issue":"7","key":"436_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108390","volume":"33","author":"AS Harutyunyan","year":"2020","unstructured":"Harutyunyan AS, Chen H, Lu T et al (2020) H3K27M in gliomas causes a one-step decrease in H3K27 methylation and reduced spreading within the constraints of H3K36 methylation. Cell Rep 33(7):108390. https:\/\/doi.org\/10.1016\/j.celrep.2020.108390","journal-title":"Cell Rep"},{"issue":"20","key":"436_CR16","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","volume":"22","author":"AP Bracken","year":"2003","unstructured":"Bracken AP (2003) EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 22(20):5323\u20135335. https:\/\/doi.org\/10.1093\/emboj\/cdg542","journal-title":"EMBO J"},{"issue":"9","key":"436_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/mc.20413","volume":"47","author":"Y Wei","year":"2008","unstructured":"Wei Y, Xia W, Zhang Z et al (2008) Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 47(9):701\u2013706. https:\/\/doi.org\/10.1002\/mc.20413","journal-title":"Mol Carcinog"},{"issue":"6","key":"436_CR18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00401-016-1540-6","volume":"131","author":"M R\u00f6hrich","year":"2016","unstructured":"R\u00f6hrich M, Koelsche C, Schrimpf D et al (2016) Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Acta Neuropathol 131(6):877\u2013887. https:\/\/doi.org\/10.1007\/s00401-016-1540-6","journal-title":"Acta Neuropathol"},{"key":"436_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah6904","author":"J Bayliss","year":"2016","unstructured":"Bayliss J, Mukherjee P, Lu C et al (2016) Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aah6904","journal-title":"Sci Transl Med."},{"key":"436_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab083","author":"S Santagata","year":"2021","unstructured":"Santagata S, Ligon KL (2021) Prognostication for meningiomas: H3K27me3 to the rescue? Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noab083","journal-title":"Neuro Oncol."},{"key":"436_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab036","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, Wang JZ, Singh O et al (2021) Loss of H3K27me3 in meningiomas. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noab036","journal-title":"Neuro Oncol."},{"key":"436_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1844-9","author":"LM Katz","year":"2018","unstructured":"Katz LM, Hielscher T, Liechty B et al (2018) Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-018-1844-9","journal-title":"Acta Neuropathol."},{"issue":"7","key":"436_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/jnen\/nlaa038","volume":"79","author":"G Gauchotte","year":"2020","unstructured":"Gauchotte G, Peyre M, Pouget C et al (2020) Prognostic value of histopathological features and loss of H3K27me3 immunolabeling in anaplastic meningioma: a multicenter retrospective study. J Neuropathol Exp Neurol 79(7):754\u2013762. https:\/\/doi.org\/10.1093\/jnen\/nlaa038","journal-title":"J Neuropathol Exp Neurol"},{"key":"436_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/neuonc\/noaa303","volume":"2020","author":"F Behling","year":"2020","unstructured":"Behling F, Fodi C, Gepfner-Tuma I et al (2020) H3K27me3 loss indicates an increased risk of recurrence in the T\u00fcbingen meningioma cohort. Neuro Oncol 2020:1\u20139. https:\/\/doi.org\/10.1093\/neuonc\/noaa303","journal-title":"Neuro Oncol"},{"issue":"800","key":"436_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.humpath.2021.06.005","volume":"115","author":"M Jung","year":"2021","unstructured":"Jung M, Kim SI, Lim KY et al (2021) The substantial loss of H3K27me3 can stratify risk in grade 2, but not in grade 3 meningioma. Hum Pathol 115(800):96\u2013103. https:\/\/doi.org\/10.1016\/j.humpath.2021.06.005","journal-title":"Hum Pathol"},{"issue":"6","key":"436_CR26","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00401-018-1844-9","volume":"135","author":"LM Katz","year":"2018","unstructured":"Katz LM, Hielscher T, Liechty B et al (2018) Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. Acta Neuropathol 135(6):955\u2013963. https:\/\/doi.org\/10.1007\/s00401-018-1844-9","journal-title":"Acta Neuropathol"},{"issue":"0123456789","key":"436_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10014-021-00422-1","volume":"3","author":"S Ammendola","year":"2022","unstructured":"Ammendola S, Barresi V (2022) Timing of H3K27me3 loss in secondary anaplastic meningiomas. Brain Tumor Pathol 3(0123456789):21\u201323. https:\/\/doi.org\/10.1007\/s10014-021-00422-1","journal-title":"Brain Tumor Pathol"},{"issue":"1","key":"436_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/bpa.12892","volume":"31","author":"AD Maier","year":"2021","unstructured":"Maier AD, Stenman A, Svahn F et al (2021) TERT promoter mutations in primary and secondary WHO grade III meningioma. Brain Pathol 31(1):61\u201369. https:\/\/doi.org\/10.1111\/bpa.12892","journal-title":"Brain Pathol"},{"key":"436_CR29","unstructured":"R Core Team. R: A language and environment for statistical computing. R Found Stat Comput. Published online 2020. https:\/\/www.r-project.org\/"},{"issue":"4","key":"436_CR30","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/his.12972","volume":"69","author":"IM Schaefer","year":"2016","unstructured":"Schaefer IM, Minkovsky A, Hornick JL (2016) H3K27me3 immunohistochemistry highlights the inactivated X chromosome (Xi) and predicts sex in non-neoplastic tissues. Histopathology 69(4):702\u2013704. https:\/\/doi.org\/10.1111\/his.12972","journal-title":"Histopathology"},{"issue":"6432","key":"436_CR31","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1126\/science.aau5870","volume":"363","author":"M Batie","year":"2019","unstructured":"Batie M, Frost J, Frost M, Wilson JW, Schofield P, Rocha S (2019) Hypoxia induces rapid changes to histone methylation and reprograms chromatin. Science (80\u2013) 363(6432):1222\u20131226. https:\/\/doi.org\/10.1126\/science.aau5870","journal-title":"Science (80\u2013)"},{"issue":"1","key":"436_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/science.1232245.Inhibition","volume":"23","author":"PW Lewis","year":"2011","unstructured":"Lewis PW, M\u00fcller MM, Koletsky MS et al (2011) Inhibition of PRC2 activity by a gain-of-function h3 mutation found in pedriatic glioblastoma. Science (80\u2013) 23(1):1\u20137. https:\/\/doi.org\/10.1126\/science.1232245.Inhibition","journal-title":"Science (80\u2013)"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-022-00436-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-022-00436-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-022-00436-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T03:33:58Z","timestamp":1664336038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-022-00436-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["436"],"URL":"https:\/\/doi.org\/10.1007\/s10014-022-00436-3","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"30 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Danish Ethics Committee (number H-6\u20132014-010).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Patient consent was waived since the study does not involve any further health risks or cause the patients any further harm and obtaining informed consent was estimated as disproportionately difficult.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}}]}}